Purchase Order HT001425PE038
Award Date 9/30/25
Potential Completion Date 9/29/30
Potential Value $185K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germany
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order contract was awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics GMBH, a for-profit international organization specializing in manufacturing and distributing medical diagnostic systems. The contract, valued at $135,766.54, is for full service analyzer support for ECN 102136. The contract has no set-aside designation and will be performed in Germany, with a period of performance through March 31, 2026. Ortho-Clinical Diagnostics GMBH is...
- This federal contract award from the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics GMBH, a for-profit international organization, is for the lease of a chemistry analyzer, full service, and delivery of reagents. The firm-fixed-price purchase order has a ceiling value of $395,085.56 and a period of performance through September 29, 2025. The contract is not designated as a set-aside. Ortho-Clinical Diagnostics GMBH is a critical supplier of advanced medical diagnostic technologies,...
- The Defense Health Agency awarded a $178,231.76 firm fixed price BPA call to Ortho-Clinical Diagnostics GMBH for Ortho-Vision Analyzer consumables supporting the Landstuhl Regional Medical Center in Germany. The contract, which carries no set-aside designation, is scheduled for completion by September 30, 2026, with an award date of October 1, 2025. Ortho-Clinical Diagnostics GMBH, a for-profit international manufacturer and distributor of diagnostic systems registered in SAM.gov since...
- The Defense Health Agency awarded a delivery order valued at $306,440.38 to Ortho-Clinical Diagnostics, Inc. on September 24, 2022, for chemistry analyzer equipment and laboratory reagents, with an ultimate completion date of June 30, 2026. This firm fixed-price contract was awarded without a set-aside designation under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule. The work will be performed in Raritan, New Jersey, where Ortho-Clinical Diagnostics...
- Ortho-Clinical Diagnostics Inc., a manufacturer of medical diagnostic equipment and reagents, has been awarded a $766,325.61 firm fixed price purchase order by the Defense Health Agency to provide chemistry testing services in Greece, New York through September 30, 2023. As the original equipment manufacturer and prime contractor, Ortho-Clinical Diagnostics will deliver the requested products and services without a set-aside designation or use of major subcontractors. This purchase order is...
- The Defense Health Agency awarded a firm fixed price purchase order to Ortho-Clinical Diagnostics GMBH, a for-profit manufacturer and distributor of diagnostic systems based in Germany, for the delivery of Micro Typing System (MTS) gel cards and bench tube testing reagents to Landstuhl, Germany. The $548,276.26 contract has a completion date of September 30, 2023 and does not have a set-aside designation. This award supports the Department of the Army Medical Command's ongoing requirement for...
- The Defense Health Agency awarded a $172,504.53 firm fixed price delivery order to Ortho-Clinical Diagnostics Inc. for the provision of VITROS 5600/XT7600 analyzers, consumables, and cost-per-reportable services for one year. The order is not associated with a set-aside program. Ortho-Clinical Diagnostics is a for-profit medical equipment manufacturer that has provided diagnostic solutions, laboratory equipment, and testing services to various federal healthcare agencies. This delivery order...
- The Defense Health Agency awarded a delivery order valued at $641,516.80 to Ortho-Clinical Diagnostics, Inc. for reagents and consumables to support laboratory operations at Fort Belvoir, Virginia. This firm fixed-price delivery order, issued under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule, carries an ultimate completion date of April 30, 2030, and represents an open competition contract with no set-aside designation. Ortho-Clinical Diagnostics, a medical equipment...
- Ortho-Clinical Diagnostics, Inc. has been awarded a delivery order valued at $456,420 by the Defense Health Agency for an analyzer and associated reagents, with performance to be completed by September 30, 2026. The contract, which became effective October 1, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competition among qualified vendors. Work will be performed at the company's facility in Raritan, New Jersey. As a leading medical...
- The Defense Health Agency awarded a firm fixed-price delivery order to Ortho-Clinical Diagnostics, Inc. valued at $303,629.39 for cost-per-test laboratory chemistry analysis services utilizing the ORTHO VITROS Analyzer. This delivery order, effective through September 30, 2025, was issued without a set-aside designation under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule. Performance will be conducted at the contractor's facility in Raritan, New Jersey....